{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T22:18:39Z","timestamp":1770243519950,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00066-025-02470-4","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:57:15Z","timestamp":1758617835000},"page":"139-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long term outcomes of prostate cancer patients aged 55\u00a0years or younger treated with definitive radiotherapy: Trod 09-005 study"],"prefix":"10.1007","volume":"202","author":[{"given":"Caglayan Selenge","family":"Beduk Esen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysenur","family":"Elmali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birhan","family":"Demirhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozan Cem","family":"Guler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selvi Tabak","family":"Dincer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilknur","family":"Alsan Cetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meral","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ertugrul","family":"Senturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap","family":"Akyurek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halil Cumhur","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulhan Guler","family":"Avci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pelin","family":"Altinok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamit","family":"Basaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokhan","family":"Ozyigit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pervin","family":"Hurmuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2742-9021","authenticated-orcid":false,"given":"Cem","family":"Onal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"issue":"3","key":"2470_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray\u00a0F, Laversanne\u00a0M, Sung\u00a0H et\u00a0al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"2470_CR2","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/jnci\/djp278","volume":"101","author":"HG Welch","year":"2009","unstructured":"Welch\u00a0HG, Albertsen\u00a0PC (2009) Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986\u20132005. J\u00a0Natl Cancer Inst 101(19):1325\u20131329. https:\/\/doi.org\/10.1093\/jnci\/djp278","journal-title":"J Natl Cancer Inst"},{"key":"2470_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14080818","author":"M De Vrieze","year":"2024","unstructured":"De Vrieze\u00a0M, Al-Monajjed\u00a0R, Boschheidgen\u00a0M et\u00a0al (2024) Prostate cancer screening in young men. J\u00a0Pers Med. https:\/\/doi.org\/10.3390\/jpm14080818","journal-title":"J Pers Med"},{"issue":"5","key":"2470_CR4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.ijrobp.2009.06.052","volume":"77","author":"RJ Burri","year":"2010","unstructured":"Burri\u00a0RJ, Ho\u00a0AY, Forsythe\u00a0K et\u00a0al (2010) Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 77(5):1315\u20131321. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.06.052","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2470_CR5","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.juro.2007.07.016","volume":"178","author":"A Magheli","year":"2007","unstructured":"Magheli\u00a0A, Rais-Bahrami\u00a0S, Humphreys\u00a0EB et\u00a0al (2007) Impact of patient age on biochemical recurrence rates following radical prostatectomy. J\u00a0Urol 178(5):1933\u20131937. https:\/\/doi.org\/10.1016\/j.juro.2007.07.016","journal-title":"J Urol"},{"issue":"3","key":"2470_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2005.10.015","volume":"77","author":"TD Nguyen","year":"2005","unstructured":"Nguyen\u00a0TD, Poortmans\u00a0PM, van der Hulst\u00a0M et\u00a0al (2005) The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55\u00a0years of age: a\u00a0rare cancer network retrospective study. Radiother Oncol 77(3):286\u2013289. https:\/\/doi.org\/10.1016\/j.radonc.2005.10.015","journal-title":"Radiother Oncol"},{"issue":"2","key":"2470_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/annonc\/mdx742","volume":"29","author":"A Pettersson","year":"2018","unstructured":"Pettersson\u00a0A, Robinson\u00a0D, Garmo\u00a0H et\u00a0al (2018) Age at diagnosis and prostate cancer treatment and prognosis: a\u00a0population-based cohort study. Ann Oncol 29(2):377\u2013385. https:\/\/doi.org\/10.1093\/annonc\/mdx742","journal-title":"Ann Oncol"},{"issue":"6","key":"2470_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrurol.2014.91","volume":"11","author":"CA Salinas","year":"2014","unstructured":"Salinas\u00a0CA, Tsodikov\u00a0A, Ishak-Howard\u00a0M et\u00a0al (2014) Prostate cancer in young men: an important clinical entity. Nat Rev Urol 11(6):317\u2013323. https:\/\/doi.org\/10.1038\/nrurol.2014.91","journal-title":"Nat Rev Urol"},{"issue":"1","key":"2470_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/cncr.11884","volume":"100","author":"SM Alibhai","year":"2004","unstructured":"Alibhai\u00a0SM, Krahn\u00a0MD, Cohen\u00a0MM et\u00a0al (2004) Is there age bias in the treatment of localized prostate carcinoma? Cancer 100(1):72\u201381. https:\/\/doi.org\/10.1002\/cncr.11884","journal-title":"Cancer"},{"issue":"1","key":"2470_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12957-020-01824-9","volume":"18","author":"Z Wang","year":"2020","unstructured":"Wang\u00a0Z, Ni\u00a0Y, Chen\u00a0J et\u00a0al (2020) The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a\u00a0systematic review and meta-analysis. World J Surg Oncol 18(1):42. https:\/\/doi.org\/10.1186\/s12957-020-01824-9","journal-title":"World J Surg Oncol"},{"issue":"1","key":"2470_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/JU.0000000000002757","volume":"208","author":"JA Eastham","year":"2022","unstructured":"Eastham\u00a0JA, Auffenberg\u00a0GB, Barocas\u00a0DA et\u00a0al (2022) Clinically localized prostate cancer: AUA\/ASTRO guideline, part\u00a0I:\u00a0introduction, risk assessment, staging, and risk-based management. J\u00a0Urol 208(1):10\u201318. https:\/\/doi.org\/10.1097\/JU.0000000000002757","journal-title":"J Urol"},{"issue":"2","key":"2470_CR12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0022-5347(05)64674-5","volume":"168","author":"CJ Rosser","year":"2002","unstructured":"Rosser\u00a0CJ, Chichakli\u00a0R, Levy\u00a0LB et\u00a0al (2002) Biochemical disease-free survival in men younger than 60\u00a0years with prostate cancer treated with external beam radiation. J\u00a0Urol 168(2):536\u2013541","journal-title":"J Urol"},{"issue":"3","key":"2470_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.radonc.2011.07.022","volume":"101","author":"TL Klayton","year":"2011","unstructured":"Klayton\u00a0TL, Ruth\u00a0K, Horwitz\u00a0EM et\u00a0al (2011) Young age under 60\u00a0years is not a\u00a0contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer. Radiother Oncol 101(3):508\u2013512. https:\/\/doi.org\/10.1016\/j.radonc.2011.07.022","journal-title":"Radiother Oncol"},{"issue":"5","key":"2470_CR14","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1097\/01.ju.0000093720.46502.24","volume":"170","author":"MJ Zelefsky","year":"2003","unstructured":"Zelefsky\u00a0MJ, Marion\u00a0C, Fuks\u00a0Z et\u00a0al (2003) Improved biochemical disease-free survival of men younger than 60\u00a0years with prostate cancer treated with high dose conformal external beam radiotherapy. J\u00a0Urol 170(5):1828\u20131832. https:\/\/doi.org\/10.1097\/01.ju.0000093720.46502.24","journal-title":"J Urol"},{"issue":"4","key":"2470_CR15","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0022-5347(01)64230-7","volume":"158","author":"AV D\u2019Amico","year":"1997","unstructured":"D\u2019Amico\u00a0AV, Whittington\u00a0R, Schultz\u00a0D et\u00a0al (1997) Outcome based staging for clinically localized adenocarcinoma of the prostate. J\u00a0Urol 158(4):1422\u20131426","journal-title":"J Urol"},{"issue":"4","key":"2470_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","volume":"65","author":"M Roach 3rd","year":"2006","unstructured":"Roach\u00a0M 3rd, Hanks\u00a0G, Thames\u00a0H Jr. et\u00a0al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO phoenix consensus conference. Int J Radiat Oncol Biol Phys 65(4):965\u2013974. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.04.029","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"2470_CR17","doi-asserted-by":"publisher","first-page":"e2332900","DOI":"10.1001\/jamanetworkopen.2023.32900","volume":"6","author":"UG Falagario","year":"2023","unstructured":"Falagario\u00a0UG, Abbadi\u00a0A, Remmers\u00a0S et\u00a0al (2023) Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy. JAMA Netw Open 6(9):e2332900. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.32900","journal-title":"JAMA Netw Open"},{"key":"2470_CR18","doi-asserted-by":"publisher","first-page":"g1502","DOI":"10.1136\/bmj.g1502","volume":"348","author":"P Sooriakumaran","year":"2014","unstructured":"Sooriakumaran\u00a0P, Nyberg\u00a0T, Akre\u00a0O et\u00a0al (2014) Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes. BMJ 348:g1502. https:\/\/doi.org\/10.1136\/bmj.g1502","journal-title":"BMJ"},{"issue":"17","key":"2470_CR19","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","volume":"388","author":"FC Hamdy","year":"2023","unstructured":"Hamdy\u00a0FC, Donovan\u00a0JL, Lane\u00a0JA et\u00a0al (2023) Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N\u00a0Engl J Med 388(17):1547\u20131558. https:\/\/doi.org\/10.1056\/NEJMoa2214122","journal-title":"N Engl J Med"},{"issue":"2","key":"2470_CR20","doi-asserted-by":"publisher","first-page":"e187765","DOI":"10.1001\/jamanetworkopen.2018.7765","volume":"2","author":"LJ Beesley","year":"2019","unstructured":"Beesley\u00a0LJ, Morgan\u00a0TM, Spratt\u00a0DE et\u00a0al (2019) Individual and population comparisons of surgery and radiotherapy outcomes in prostate cancer using bayesian multistate models. JAMA Netw Open 2(2):e187765. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.7765","journal-title":"JAMA Netw Open"},{"issue":"15","key":"2470_CR21","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","volume":"375","author":"FC Hamdy","year":"2016","unstructured":"Hamdy\u00a0FC, Donovan\u00a0JL, Lane\u00a0JA et\u00a0al (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N\u00a0Engl J Med 375(15):1415\u20131424. https:\/\/doi.org\/10.1056\/NEJMoa1606220","journal-title":"N Engl J Med"},{"issue":"3","key":"2470_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","volume":"80","author":"LF Valle","year":"2021","unstructured":"Valle\u00a0LF, Lehrer\u00a0EJ, Markovic\u00a0D et\u00a0al (2021) A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER). Eur Urol 80(3):280\u2013292. https:\/\/doi.org\/10.1016\/j.eururo.2020.11.010","journal-title":"Eur Urol"},{"issue":"2","key":"2470_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.euo.2018.12.011","volume":"3","author":"G Ingrosso","year":"2020","unstructured":"Ingrosso\u00a0G, Becherini\u00a0C, Lancia\u00a0A et\u00a0al (2020) Nonsurgical salvage local therapies for radiorecurrent prostate cancer: a\u00a0systematic review and meta-analysis. Eur Urol Oncol 3(2):183\u2013197. https:\/\/doi.org\/10.1016\/j.euo.2018.12.011","journal-title":"Eur Urol Oncol"},{"key":"2470_CR24","doi-asserted-by":"publisher","first-page":"858","DOI":"10.2340\/1651-226x.2024.40759","volume":"63","author":"C Onal","year":"2024","unstructured":"Onal\u00a0C, Guler\u00a0OC, Elmali\u00a0A et\u00a0al (2024) The impact of age on clinicopathological features and treatment results in patients with localised prostate cancer receiving definitive radiotherapy. Acta Oncol 63:858\u2013866. https:\/\/doi.org\/10.2340\/1651-226x.2024.40759","journal-title":"Acta Oncol"},{"issue":"1","key":"2470_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00066-024-02288-6","volume":"201","author":"C Zamboglou","year":"2025","unstructured":"Zamboglou\u00a0C, Aebersold\u00a0DM, Albrecht\u00a0C et\u00a0al (2025) The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a\u00a0statement of the prostate cancer working group of the german society of radiation oncology (DEGRO). Strahlenther Onkol 201(1):4\u201310. https:\/\/doi.org\/10.1007\/s00066-024-02288-6","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"2470_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0360-3016(96)00017-x","volume":"35","author":"GM Freedman","year":"1996","unstructured":"Freedman GM, Hanlon AL, Lee WR, Hanks GE (1996) Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation. Int J Radiat Oncol Biol Phys 35(2):243\u2013250. https:\/\/doi.org\/10.1016\/0360-3016(96)00017-x","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2470_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.prnil.2017.07.002","volume":"6","author":"L Tan","year":"2018","unstructured":"Tan\u00a0L, Wang\u00a0LL, Ranasinghe\u00a0W et\u00a0al (2018) Survival outcomes of younger men (\u3008\u202f55\u00a0years) undergoing radical prostatectomy. Prostate Int 6(1):31\u201335. https:\/\/doi.org\/10.1016\/j.prnil.2017.07.002","journal-title":"Prostate Int"},{"key":"2470_CR28","doi-asserted-by":"publisher","first-page":"9858923","DOI":"10.1155\/2017\/9858923","volume":"2017","author":"D Milonas","year":"2017","unstructured":"Milonas\u00a0D, Venclovas\u00a0Z, Gudinaviciene\u00a0I et\u00a0al (2017) Long-term oncological outcomes for young men undergoing radical prostatectomy for localized prostate cancer. Biomed Res Int 2017:9858923. https:\/\/doi.org\/10.1155\/2017\/9858923","journal-title":"Biomed Res Int"},{"issue":"4","key":"2470_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.urology.2005.10.027","volume":"67","author":"CJ Rosser","year":"2006","unstructured":"Rosser\u00a0CJ, Kamat\u00a0AM, Wang\u00a0X et\u00a0al (2006) Biochemical disease-free survival in men younger than 60\u00a0years with prostate cancer treated with radical prostatectomy. Urology 67(4):769\u2013773. https:\/\/doi.org\/10.1016\/j.urology.2005.10.027","journal-title":"Urology"},{"issue":"5","key":"2470_CR30","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.urology.2005.11.035","volume":"67","author":"M Roupret","year":"2006","unstructured":"Roupret\u00a0M, Fromont\u00a0G, Bitker\u00a0MO et\u00a0al (2006) Outcome after radical prostatectomy in young men with or without a\u00a0family history of prostate cancer. Urology 67(5):1028\u20131032. https:\/\/doi.org\/10.1016\/j.urology.2005.11.035","journal-title":"Urology"},{"issue":"11","key":"2470_CR31","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1200\/jco.20.03282","volume":"39","author":"V Murthy","year":"2021","unstructured":"Murthy\u00a0V, Maitre\u00a0P, Kannan\u00a0S et\u00a0al (2021) Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase\u00a0III randomized controlled trial. J\u00a0Clin Oncol 39(11):1234\u20131242. https:\/\/doi.org\/10.1200\/jco.20.03282","journal-title":"J Clin Oncol"},{"issue":"7","key":"2470_CR32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1200\/jco.20.02873","volume":"39","author":"LGW Kerkmeijer","year":"2021","unstructured":"Kerkmeijer\u00a0LGW, Groen\u00a0VH, Pos\u00a0FJ et\u00a0al (2021) Focal boost to the Intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase\u00a0III trial. J\u00a0Clin Oncol 39(7):787\u2013796. https:\/\/doi.org\/10.1200\/jco.20.02873","journal-title":"J Clin Oncol"},{"issue":"12","key":"2470_CR33","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/pros.24558","volume":"83","author":"C Onal","year":"2023","unstructured":"Onal\u00a0C, Erbay\u00a0G, Guler\u00a0OC et\u00a0al (2023) Treatment outcomes of simultaneous integrated boost to intraprostatic lesions with external beam radiotherapy in localized prostate cancer patients. Prostate 83(12):1158\u20131166. https:\/\/doi.org\/10.1002\/pros.24558","journal-title":"Prostate"},{"issue":"8","key":"2470_CR34","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1097\/rlu.0000000000005284","volume":"49","author":"C Onal","year":"2024","unstructured":"Onal\u00a0C, Guler\u00a0OC, Erpolat\u00a0P et\u00a0al (2024) Evaluation of treatment outcomes of prostate cancer patients with lymph node metastasis treated with definitive radiotherapy: comparative analysis of PSMA PET\/CT and conventional imaging. Clin Nucl Med 49(8):e383\u2013e389. https:\/\/doi.org\/10.1097\/rlu.0000000000005284","journal-title":"Clin Nucl Med"},{"key":"2470_CR35","doi-asserted-by":"publisher","first-page":"i851","DOI":"10.1136\/bmj.i851","volume":"352","author":"CJ Wallis","year":"2016","unstructured":"Wallis\u00a0CJ, Mahar\u00a0AL, Choo\u00a0R et\u00a0al (2016) Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis. BMJ 352:i851. https:\/\/doi.org\/10.1136\/bmj.i851","journal-title":"BMJ"},{"key":"2470_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.radonc.2021.06.023","volume":"161","author":"EC Dee","year":"2021","unstructured":"Dee\u00a0EC, Muralidhar\u00a0V, King\u00a0MT et\u00a0al (2021) Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques. Radiother Oncol 161:241\u2013250. https:\/\/doi.org\/10.1016\/j.radonc.2021.06.023","journal-title":"Radiother Oncol"},{"key":"2470_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15143734","author":"J Drobner","year":"2023","unstructured":"Drobner\u00a0J, Kaldany\u00a0A, Shah\u00a0MS et\u00a0al (2023) The role of salvage radical prostatectomy in patients with radiation-resistant prostate cancer. Cancers. https:\/\/doi.org\/10.3390\/cancers15143734","journal-title":"Cancers"},{"issue":"4","key":"2470_CR38","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/01.ju.0000155534.54711.60","volume":"173","author":"JF Ward","year":"2005","unstructured":"Ward\u00a0JF, Sebo\u00a0TJ, Blute\u00a0ML et\u00a0al (2005) Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J\u00a0Urol 173(4):1156\u20131160. https:\/\/doi.org\/10.1097\/01.ju.0000155534.54711.60","journal-title":"J Urol"},{"issue":"8","key":"2470_CR39","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.canrad.2020.03.009","volume":"24","author":"G Ozyigit","year":"2020","unstructured":"Ozyigit\u00a0G, Hurmuz\u00a0P, Akinci\u00a0D et\u00a0al (2020) Hyaluronic acid spacer in focal prostate reirradiation: a\u00a0single centre experience. Cancer Radiother 24(8):805\u2013811. https:\/\/doi.org\/10.1016\/j.canrad.2020.03.009","journal-title":"Cancer Radiother"},{"key":"2470_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00927-8","author":"Y Meng","year":"2024","unstructured":"Meng\u00a0Y, Liu\u00a0J, Shen\u00a0B et\u00a0al (2024) Evaluation of the safety and efficacy of stereotactic body radiotherapy for radio-recurrent prostate cancer: a\u00a0systematic review and meta-analysis. Prostate Cancer Prostatic Dis. https:\/\/doi.org\/10.1038\/s41391-024-00927-8","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"16","key":"2470_CR41","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1056\/NEJMoa2303974","volume":"389","author":"SJ Freedland","year":"2023","unstructured":"Freedland\u00a0SJ, de Almeida\u00a0LM, De Giorgi\u00a0U et\u00a0al (2023) Improved outcomes with enzalutamide in biochemically recurrent prostate cancer. N\u00a0Engl J Med 389(16):1453\u20131465. https:\/\/doi.org\/10.1056\/NEJMoa2303974","journal-title":"N Engl J Med"},{"issue":"17","key":"2470_CR42","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1200\/jco.2016.68.0058","volume":"35","author":"MS Leapman","year":"2017","unstructured":"Leapman\u00a0MS, Cowan\u00a0JE, Nguyen\u00a0HG et\u00a0al (2017) Active surveillance in younger men with prostate cancer. J\u00a0Clin Oncol 35(17):1898\u20131904. https:\/\/doi.org\/10.1200\/jco.2016.68.0058","journal-title":"J Clin Oncol"},{"issue":"9","key":"2470_CR43","doi-asserted-by":"publisher","first-page":"e2231015","DOI":"10.1001\/jamanetworkopen.2022.31015","volume":"5","author":"E Ventimiglia","year":"2022","unstructured":"Ventimiglia\u00a0E, Bill-Axelson\u00a0A, Bratt\u00a0O et\u00a0al (2022) Long-term outcomes among men undergoing active surveillance for prostate cancer in Sweden. JAMA Netw Open 5(9):e2231015. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.31015","journal-title":"JAMA Netw Open"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02470-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-025-02470-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02470-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:06:28Z","timestamp":1770195988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-025-02470-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2470"],"URL":"https:\/\/doi.org\/10.1007\/s00066-025-02470-4","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.S.\u00a0Beduk\u00a0Esen, A.\u00a0Elmali, B.\u00a0Demirhan, O.C.\u00a0Guler, S.T.\u00a0Dincer, I.\u00a0Alsan Cetin, M.\u00a0Kurt, M.\u00a0Akin, E.\u00a0Senturk, S.\u00a0Akyurek, H.C.\u00a0Yildirim, G.G.\u00a0Avci, P.\u00a0Altinok, H.\u00a0Basaran, G.\u00a0Ozyigit, P.\u00a0Hurmuz and C.\u00a0Onal declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}